Annals of internal medicine
-
There currently is debate regarding whether U. S. institutions and clinicians may or should restrict patient access to COVID-19 drugs and vaccines that have been granted emergency use authorization by the U. ⋯ Food and Drug Administration. The authors provide their views on the legal, ethical, and clinical ramifications of such restriction.